A new review including over 100 clinical trials has found that no induction method was clearly effective than low-dose vaginal misoprostol, although some methods were less effective and safety ...

ePlus inc.'s delivered strong growth across sales, billings, EBITDA, and net income in Q2 FY26 with gross billings crossing $1 billion for the first time, confirming scale momentum. ePlus' headline ...

In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved the first at-home brain-stimulation device to treat moderate to severe major ...

Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...